| | | |   | | | | By Tara Bannow Damian Dovarganes/AP Almost 90% of health care companies Moody’s classifies as being under financial stress are owned by private equity. Read More | | By Sarah Owermohle Adobe The Biden administration signaled Monday that it will require health plans on federal exchanges to cover more of the costs of generic drugs. Read More | | By Lev Facher Kristoffer Tripplaar/Sipa USA/AP The proposal would codify pandemic exceptions that allowed telehealth prescription of buprenorphine and take-home supplies of methadone. Read More | | Sponsored Insight by Regeneron Is boldness the solution to R&D challenges with bispecific antibodies? Despite their inherent challenges, bispecific antibodies (bsAbs) hold promise in improving the future of cancer care. T cell manipulation via bsAbs creates room for flexibility in immunotherapy research, with the ability to be studied individually as monotherapy or in combination with other oncologic treatments. Regeneron has spent over a decade researching bispecific antibodies, following the science to gain an understanding of the bsAbs landscape to utilize them in emerging research in oncology. Learn more. | | By Tony Paquin and David Sanders Adobe Reinvigorating the domestic supply chain is an important step toward protecting Americans' health and the country's national security. Read More | |
No comments